Evidence map›Paper›PMID 29868607›Full record

ArticleFrontiers in molecular biosciences2018

The Chaperonin GroEL: A Versatile Tool for Applied Biotechnology Platforms.

Pierce T O'Neil, Alexandra J Machen, Benjamin C Deatherage, Caleb Trecazzi, Alexander Tischer, Venkata R Machha, Matthew T Auton, Michael R Baldwin, Tommi A White, Mark T Fisher

Abstract read
In one paragraph

Article in Frontiers in molecular biosciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Evaluation of PLGA-Encapsulated Recombinant GroEL ofAvicenna journal of medical biotechnology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Pierce T O'NeilDepartment of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS, United States.
Alexandra J MachenDepartment of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS, United States.
Benjamin C DeatherageDepartment of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS, United States.
Caleb TrecazziDepartment of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS, United States.
Alexander TischerDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, United States.
Venkata R MachhaDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, United States.
Matthew T AutonDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, United States.
Michael R BaldwinDepartment of Molecular Microbiology and Immunology, University of Missouri, Columbia, MO, United States.
Tommi A WhiteDepartment of Biochemistry, University of Missouri, Columbia, MO, United States.
Mark T FisherDepartment of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS, United States.

Funding

PHARMACEUTICAL ASPECTS OF BIOTECHNOLOGY TRAININGT32GM008359 · NIGMS · UNIVERSITY OF KANSAS LAWRENCE · PI SIAHAAN, TERUNA J., VOLKIN, DAVID · 1989 to 2018
$5.0M
Thermodynamics of the Conformational Activation of Von Willebrand FactorR01HL109109 · NHLBI · MAYO CLINIC ROCHESTER · PI AUTON, MATTHEW · 2011 to 2015
$1.7M
CryoEM analysis of Anthrax Toxin Pore ComplexesR01AI090085 · NIAID · UNIVERSITY OF KANSAS MEDICAL CENTER · PI FISHER, MARK T · 2011 to 2013
$948k
Structures of Membrane bound and Inserted Tetanus ToxinR21AI121492 · NIAID · UNIVERSITY OF MISSOURI-COLUMBIA · PI BALDWIN, MICHAEL R, FENTON, ARON W · 2017 to 2018
$431k
NHLBI NIH HHS R01 HL109109NIAID NIH HHS R01 AI090085NIAID NIH HHS R21 AI121492NIGMS NIH HHS T32 GM008359
6 · The paper itself

Abstract

The nucleotide-free chaperonin GroEL is capable of capturing transient unfolded or partially unfolded states that flicker in and out of existence due to large-scale protein dynamic vibrational modes. In this work, three short vignettes are presented to highlight our continuing advances in the application of GroEL biosensor biolayer interferometry (BLI) technologies and includes expanded uses of GroEL as a molecular scaffold for electron microscopy determination. The first example presents an extension of the ability to detect dynamic pre-aggregate transients in therapeutic protein solutions where the assessment of the kinetic stability of any folded protein or, as shown herein, quantitative detection of mutant-type protein when mixed with wild-type native counterparts. Secondly, using a BLI denaturation pulse assay with GroEL, the comparison of kinetically controlled denaturation isotherms of various von Willebrand factor (vWF) triple A domain mutant-types is shown. These mutant-types are single point mutations that locally disorder the A1 platelet binding domain resulting in one gain of function and one loss of function phenotype. Clear, separate, and reproducible kinetic deviations in the mutant-type isotherms exist when compared with the wild-type curve. Finally, expanding on previous electron microscopy (EM) advances using GroEL as both a protein scaffold surface and a release platform, examples are presented where GroEL-protein complexes can be imaged using electron microscopy tilt series and the low-resolution structures of aggregation-prone proteins that have interacted with GroEL. The ability of GroEL to bind hydrophobic regions and transient partially folded states allows one to employ this unique molecular chaperone both as a versatile structural scaffold and as a sensor of a protein's folded states.

Indexed as

anthrax toxinbiolayer interferometrychaperonin GroELcryoSPARCelectron microscopytetanus neurotoxintilt seriesvon Willebrand Factor

Identifiers

PMID29868607
PMCPMC5962814

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.